It is estimated that MUS accounts for approximately 20% of new consultations in primary care,
4 5 52% of new referrals in secondary care
6 and 20%–25% of all frequent attenders at medical clinics.
7 8 Patients with MUS are commonly referred for multiple investigations and assessments with little benefit, so are needlessly costly for healthcare systems
9–11 and account for approximately 10% of the total National Health Service (NHS) expenditure for the working-age adult population in England. The annual cost attributable to MUS due to lost productivity and decreased quality of life is over £14 billion to the UK economy.
12 However, there is no satisfactory review of the available literature to support such estimations.